Overview

Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This study evaluated the efficacy (blood pressure lowering effect) and safety of aliskiren/amlodipine/hydrochlorothiazide in patients with moderate to severe hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Hydrochlorothiazide